These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
680 related items for PubMed ID: 6998023
41. Intermittent chemotherapy or improvement of initial treatment in tuberculosis. Oka S. Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334 [No Abstract] [Full Text] [Related]
42. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol]. Virsik K, Kruty R, Matula F, Badalik L. Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902 [No Abstract] [Full Text] [Related]
43. [Experimental study of therapeutic effect of various antibacterial drug combinations]. Kozulitsyna TI, Uvarova OA, Golyshevskaia VI, El'shanskaia MP. Probl Tuberk; 1980 Jul; (7):49-53. PubMed ID: 7413637 [No Abstract] [Full Text] [Related]
44. [Rifampin in the treatment of children with newly detected intrathoracic tuberculosis]. Gvasaliia T. Probl Tuberk; 1984 Apr; (4):46-50. PubMed ID: 6610872 [No Abstract] [Full Text] [Related]
45. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis]. Toyota E, Suzuki T, Tagawa K, Takahara M, Ito M, Arai T, Kabe J, Baba H. Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317 [Abstract] [Full Text] [Related]
48. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)]. Kuze F, Lee Y, Maekawa N, Suzuki Y. Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152 [No Abstract] [Full Text] [Related]
50. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin]. González Montaner LJ, Palma Beltrán O, Abbate E, Dambrosi A, Mosca C. Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262 [No Abstract] [Full Text] [Related]
51. Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987. Trkanjec Z, Tekavec J. Tuber Lung Dis; 1993 Feb; 74(1):16-9. PubMed ID: 8495013 [Abstract] [Full Text] [Related]
52. [Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)]. Baba H, Shinkai A, Azuma Y. Kekkaku; 1978 May; 53(5):287-94. PubMed ID: 671950 [No Abstract] [Full Text] [Related]
54. [New and future drugs in pulmonary tuberculosis]. Grosset JH, Truffot-Pernot C, Lecoeur H. Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565 [No Abstract] [Full Text] [Related]
55. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy]. Virchow C. Munch Med Wochenschr; 1969 Aug 29; 111(35):1717-22. PubMed ID: 4309162 [No Abstract] [Full Text] [Related]
56. General considerations in intermittent drug therapy of pulmonary tuberculosis. Fox W. Postgrad Med J; 1971 Nov 29; 47(553):729-36. PubMed ID: 4110537 [Abstract] [Full Text] [Related]